Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes

NCT00734253 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

317

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Pyridoxamine Dihydrochloride
DRUG: Pyridoxamine Dihydrochloride
DRUG: Placebo

Sponsor

NephroGenex, Inc.

Collaborators

[object Object]
[object Object]